These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38081829)

  • 1. High-throughput target trial emulation for Alzheimer's disease drug repurposing with real-world data.
    Zang C; Zhang H; Xu J; Zhang H; Fouladvand S; Havaldar S; Cheng F; Chen K; Chen Y; Glicksberg BS; Chen J; Bian J; Wang F
    Nat Commun; 2023 Dec; 14(1):8180. PubMed ID: 38081829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
    Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
    J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication-Wide Association Study Plus (MWAS+): A Proof of Concept Study on Drug Repurposing.
    Cheng Y; Zamrini E; Ahmed A; Wu WC; Shao Y; Zeng-Treitler Q
    Med Sci (Basel); 2022 Aug; 10(3):. PubMed ID: 36135833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's Disease.
    Reed C; Happich M; Raskin J; Tockhorn-Heidenreich A; Belger M
    J Prev Alzheimers Dis; 2019; 6(2):90-99. PubMed ID: 30756115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation.
    Català M; Burn E; Rathod-Mistry T; Xie J; Delmestri A; Prieto-Alhambra D; Jödicke AM
    Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 37833846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug Repositioning for Alzheimer's Disease].
    Ihara M; Saito S
    Brain Nerve; 2019 Sep; 71(9):961-970. PubMed ID: 31506398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs.
    Ihara M; Saito S
    J Alzheimers Dis; 2020; 74(4):1013-1028. PubMed ID: 32144994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational drug repositioning of atorvastatin for ulcerative colitis.
    Bai L; Scott MKD; Steinberg E; Kalesinskas L; Habtezion A; Shah NH; Khatri P
    J Am Med Inform Assoc; 2021 Oct; 28(11):2325-2335. PubMed ID: 34529084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity score analysis methods with balancing constraints: A Monte Carlo study.
    Li Y; Li L
    Stat Methods Med Res; 2021 Apr; 30(4):1119-1142. PubMed ID: 33525962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity.
    Parsons CG
    Neuropharmacology; 2019 Mar; 147():4-10. PubMed ID: 30165077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling Alzheimer's Disease with Existing Drugs: A Promising Strategy for Bypassing Obstacles.
    Rampa A; Gobbi S; Belluti F; Bisi A
    Curr Med Chem; 2021; 28(12):2305-2327. PubMed ID: 32867634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives.
    de Castro AA; da Cunha EFF; Pereira AF; Soares FV; Leal DHS; Kuca K; Ramalho TC
    Curr Alzheimer Res; 2018; 15(12):1161-1178. PubMed ID: 30101709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repositioning in Alzheimer's disease.
    Corbett A; Williams G; Ballard C
    Front Biosci (Schol Ed); 2015 Jun; 7(1):184-8. PubMed ID: 25961694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning identifies candidates for drug repurposing in Alzheimer's disease.
    Rodriguez S; Hug C; Todorov P; Moret N; Boswell SA; Evans K; Zhou G; Johnson NT; Hyman BT; Sorger PK; Albers MW; Sokolov A
    Nat Commun; 2021 Feb; 12(1):1033. PubMed ID: 33589615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical genetics-based drug repurposing for Alzheimer's disease.
    Zhang XZ; Quan Y; Tang GY
    Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Tacrine for Alzheimer's disease.
    Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000202. PubMed ID: 17636619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches.
    Singh RK
    Curr Neuropharmacol; 2020; 18(9):868-882. PubMed ID: 31989900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can commonly prescribed drugs be repurposed for the prevention or treatment of Alzheimer's and other neurodegenerative diseases? Protocol for an observational cohort study in the UK Clinical Practice Research Datalink.
    Walker VM; Davies NM; Jones T; Kehoe PG; Martin RM
    BMJ Open; 2016 Dec; 6(12):e012044. PubMed ID: 27965247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.